key: cord-1023477-c7jhbxcb authors: Stegger, M.; Edslev, S. M.; Sieber, R. N.; Ingham, A. C.; Ng, K. L.; Tang, M.-H. E.; Alexandersen, S.; Fonager, J.; Legarth, R.; Utko, M.; Wilkowski, B.; Gunalan, V.; Bennedbaek, M.; Byberg-Grauholm, J.; Moeller, C. H.; Christiansen, L. E.; Svarrer, C. W.; Ellegaard, K.; Baig, S.; Johannesen, T. B.; Espenhain, L.; Skov, R.; Cohen, A. S.; Larsen, N. B.; Soerensen, K. M.; White, E. D.; Lillebaek, T.; Ullum, H.; Krause, T. G.; Fomsgaard, A.; Ethelberg, S.; Rasmussen, M. title: Occurrence and significance of Omicron BA.1 infection followed by BA.2 reinfection date: 2022-02-22 journal: nan DOI: 10.1101/2022.02.19.22271112 sha: b7d2ce40e0fda25fd25715a9a6262a214f1aa8e2 doc_id: 1023477 cord_uid: c7jhbxcb The newly found Omicron SARS-CoV-2 variant of concern has rapidly spread worldwide. Omicron carries numerous mutations in key regions and is associated with increased transmissibility and immune escape. The variant has recently been divided into four subvariants with substantial genomic differences, in particular between Omicron BA.1 and BA.2. With the surge of Omicron subvariants BA.1 and BA.2, a large number of reinfections from earlier cases has been observed, raising the question of whether BA.2 specifically can escape the natural immunity acquired shortly after a BA.1 infection. To investigate this, we selected a subset of samples from more than 1,8 million cases of infections in the period from November 22, 2021, until February 11, 2022. Here, individuals with two positive samples, more than 20 and less than 60 days apart, were selected. From a total of 187 reinfection cases, we identified 47 instances of BA.2 reinfections shortly after a BA.1 infection, mostly in young unvaccinated individuals with mild disease not resulting in hospitalization or death. In conclusion, we provide evidence that Omicron BA.2 reinfections do occur shortly after BA.1 infections but are rare. Since the first report of a new SARS-CoV-2 variant of concern (VOC), Omicron (Pango 61 lineage B.1.1.529), on November 19, 2021 1 , this VOC has rapidly disseminated globally and 62 now dominates in many countries. Omicron carries more than 30 mutations and deletions in 63 the spike gene compared to the original Wuhan strain and is associated with increased 64 transmissibility 2 and immune escape 3, 4 . Studies indicate that the Omicron variant results in 65 less severe disease outcomes than Delta 5 . Currently, Omicron is subdivided into four 66 subvariants, BA.1, BA. the remaining samples were selected for WGS. In total, 1,056 samples were included ( Figure 138 1). All samples were subjected to quantitative PCR for indication of viral load by cycle 139 threshold (Ct) value where a paired Wilcoxon signed-rank test was used for comparison 140 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 22, 2022. ; between the Omicron BA.1 to BA. 2 (Table 190 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Table 218 2). 219 None of the 47 individuals with Omicron BA.1 to BA2 reinfections had been hospitalized or 220 died during the follow-up study period. Detailed information of symptoms was obtained for 221 33 of the cases, whereof most of them reported symptoms during both infections ( Figure 2 , 222 Supplementary Table 3) . Twenty-eight (85%) had symtoms during the Omicron BA.2 223 reinfection, though mainly mild disease (symptoms for a few days) (Figure 2A ). The mean 224 duration of symptoms were four days for both infection rounds. The distribution of reported 225 symptoms did not differ markedly between the two infections ( Figure 2B ). For the first 226 infection, the most common indication for testing was exposure as close contact to a person 227 testing positive (53%) while the primary indication for testing for the second infection was 228 experiencing symptoms (47%). 229 The phylogeny of the paired Omicron BA.1 and BA.2 genomes with the randomly sampled 230 Danish BA.1 and BA.2 genomes, did not show any distinct variant(s) causing the reinfection 231 (BA.2) nor any primary Omicron BA.1 clusters that in some way could be related to later 232 reinfections (Figure 3 ). Despite differences in age group and vaccination status distributions 233 between the paired reinfection data and the randomly sampled data, no clustering of samples 234 by these parameters was evident. In addition, no mutations were observed in the spike protein 235 other than those seen in general among Omicron BA.2 cases. It appears that for the initial 236 Omicron BA.1 infection, the levels of genomic RNA (mapped at nucleotide 55) and for the 237 two mapped subgenomic RNAs for Spike and Nucleoprotein, respectively, did not differ 238 between the study population and the randomly selected BA.1 samples used for comparison 239 (Supplementary Figure 2) . In contrast, for the subsequent Omicron BA.2 infection, the 240 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 22, 2022. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 22, 2022. ; We observed significantly reduced overall viral load in secondary BA.2 infection samples 290 compared to initial infection together with a lower ratio of subgenomic to genomic RNA. 291 Taken together, this may indicate a more superficial and transient secondary infection that 292 could be explained by T cell-mediated immunity obtained during the first infection 17 . We 293 have previously speculated that infections in the early stage may be associated with the 294 pattern that we see here for the Omicron BA.2 study population 18 , and it is possible that the 295 BA.2 infection in these individuals, happening within a short window after an initial BA.1 296 infection, may somehow differ, perhaps by being more superficial or transient than the BA.2 297 infections observed in the randomly selected samples used for comparison. 298 In conclusion, we provide evidence that Omicron BA. 2 The authors declare no competing interests. 319 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 22, 2022. ; Wuhan reference . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 22, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 SARS-CoV-2 Omicron VOC 393 Transmission in Danish Households Omicron extensively but incompletely escapes 396 Pfizer BNT162b2 neutralization Increased immune escape of the new SARS-CoV-2 variant 398 of concern Omicron Reduced risk of hospitalisation 401 among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 402 variant compared with the Delta variant Weekly epidemiological update: Omicron variant of concern (VOC) 405 -week 2 (data as of Mutational and phylogenetic analyses of the two lineages of 409 the Omicron variant Electronic reporting of diagnostic 411 laboratory test results from all healthcare sectors is a cornerstone of national 412 preparedness and control of COVID-19 in Denmark Rapid surveillance platforms for key SARS-415 CoV-2 mutations in Denmark Transmission of SARS-CoV-2 Omicron 418 VOC subvariants BA.1 and BA.2: Evidence from Danish Households Tracking the international spread of SARS-CoV-421 2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch MAFFT multiple sequence alignment software version 7: 424 improvements in performance and usability A new coronavirus associated with human respiratory 427 disease in China IQ-TREE: a fast and effective 429 stochastic algorithm for estimating maximum-likelihood phylogenies SARS-CoV-2 genomic and subgenomic 432 RNAs in diagnostic samples are not an indicator of active replication Children develop robust and sustained cross-435 reactive spike-specific immune responses to SARS-CoV-2 infection Escape from recognition of SARS-CoV-2 438 variant spike epitopes but overall preservation of T cell immunity